| Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study A Manfredi, G Cassone, F Furini, E Gremese, V Venerito, F Atzeni, ... Internal Medicine Journal 50 (9), 1085-1090, 2020 | 104 | 2020 |
| Unveiling the efficacy, safety, and tolerability of anti-interleukin-1 treatment in monogenic and multifactorial autoinflammatory diseases A Bettiol, G Lopalco, G Emmi, L Cantarini, ML Urban, A Vitale, N Denora, ... International journal of molecular sciences 20 (8), 1898, 2019 | 72 | 2019 |
| Cytokine signatures in mucocutaneous and ocular behcet’s disease G Lopalco, OM Lucherini, A Lopalco, V Venerito, C Fabiani, B Frediani, ... Frontiers in Immunology 8, 200, 2017 | 68 | 2017 |
| Safety of abatacept in Italian patients with rheumatoid arthritis and interstitial lung disease: a multicenter retrospective study G Cassone, A Manfredi, F Atzeni, V Venerito, C Vacchi, V Picerno, F Furini, ... Journal of Clinical Medicine 9 (1), 277, 2020 | 64 | 2020 |
| Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia … A Manfredi, G Cassone, S Cerri, V Venerito, AL Fedele, M Trevisani, ... BMC pulmonary medicine 19, 1-6, 2019 | 60 | 2019 |
| Ten-year retention rate of infliximab in patients with Behçet’s disease-related uveitis C Fabiani, J Sota, A Vitale, G Emmi, L Vannozzi, D Bacherini, G Lopalco, ... Ocular immunology and inflammation 27 (1), 34-39, 2019 | 47 | 2019 |
| The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment G Lopalco, D Rigante, L Cantarini, M Imazio, A Lopalco, G Emmi, ... Trends in Cardiovascular Medicine 31 (5), 265-274, 2021 | 44 | 2021 |
| COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence V Venerito, G Lopalco, F Iannone Rheumatology international 40 (5), 827-828, 2020 | 42 | 2020 |
| COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies A Gil‐Vila, N Ravichandran, A Selva‐O'Callaghan, P Sen, A Nune, ... Muscle & nerve 66 (4), 426-437, 2022 | 35 | 2022 |
| Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet’s disease OM Lucherini, G Lopalco, L Cantarini, G Emmi, A Lopalco, V Venerito, ... Immunology Letters 201, 38-44, 2018 | 35 | 2018 |
| Adalimumab accounts for long‐term control of noninfectious uveitis also in the absence of concomitant DMARD treatment: a multicenter retrospective study A Bitossi, A Bettiol, E Silvestri, G Di Scala, D Bacherini, G Lopalco, ... Mediators of Inflammation 2019 (1), 1623847, 2019 | 34 | 2019 |
| A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study V Venerito, O Angelini, G Cazzato, G Lopalco, E Maiorano, A Cimmino, ... Internal and Emergency Medicine, 1-9, 2021 | 32 | 2021 |
| Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis F Iannone, M Nivuori, M Fornaro, V Venerito, F Cacciapaglia, G Lopalco Rheumatology 59 (7), 1599-1606, 2020 | 32 | 2020 |
| Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet’s disease G Lopalco, V Venerito, P Leccese, G Emmi, L Cantarini, N Lascaro, ... Annals of the rheumatic diseases 78 (12), 1736-1737, 2019 | 27 | 2019 |
| Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors V Venerito, P Stefanizzi, M Fornaro, F Cacciapaglia, S Tafuri, S Perniola, ... RMD open 8 (1), e001847, 2022 | 25 | 2022 |
| Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an AI approach S Bellando-Randone, E Russo, V Venerito, M Matucci-Cerinic, F Iannone, ... Journal of Personalized Medicine 11 (7), 625, 2021 | 25 | 2021 |
| Formalin-fixed and paraffin-embedded samples for next generation sequencing: problems and solutions G Cazzato, C Caporusso, F Arezzo, A Cimmino, A Colagrande, V Loizzi, ... Genes 12 (10), 1472, 2021 | 24 | 2021 |
| Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome E Silvestri, A Bitossi, A Bettiol, G Emmi, ML Urban, I Mattioli, G Di Scala, ... Inflammopharmacology 28, 711-718, 2020 | 24 | 2020 |
| AI am a rheumatologist: a practical primer to large language models for rheumatologists V Venerito, E Bilgin, F Iannone, S Kiraz Rheumatology 62 (10), 3256-3260, 2023 | 23 | 2023 |
| A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis V Venerito, G Lopalco, F Cacciapaglia, M Fornaro, F Iannone Clinical Rheumatology 38 (5), 1309-1317, 2019 | 23 | 2019 |
